Accuratus Lab Services and its principal owner, Ampersand Capital Partners, have acquired Array BioPharma’s chemistry, manufacturing and controls (CMC) operation. Accuratus, formed in July 2014 when ATS Labs acquired Microtest Labs, provides GMP and GLP analytical and microbial testing services to the medical device and biopharma industries, as well as manufacturers of EPA-regulated consumer products. Array’s CMC operation expands its CDMO services for the pharma industry.   The Array CM...